Log in

Relevant bibliographies by topics / Glycogen storage disease type III / Journal articles

To see the other types of publications on this topic, follow the link: Glycogen storage disease type III.

Journal articles on the topic 'Glycogen storage disease type III'

Author: Grafiati

Published: 14 December 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Glycogen storage disease type III.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Carvalho, Julene S., Eurem E. Matthews, James V. Leonard, and John Deanfield. "Cardiomyopathy of glycogen storage disease type III." Heart and Vessels 8, no. 3 (1993): 155–59. http://dx.doi.org/10.1007/bf01744800.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Labrune, Philippe, Pascale Trioche, Isabelle Duvaltier, Paquita Chevalier, and Michel Odièvre. "Hepatocellular Adenomas in Glycogen Storage Disease Type I and III: A Series of 43 Patients and Review of the Literature." Journal of Pediatric Gastroenterology and Nutrition 24, no. 3 (1997): 276–79. http://dx.doi.org/10.1002/j.1536-4801.1997.tb00424.x.

Full text

Abstract:

Background:Hepatocellular adenomas may develop in patients with glycogen storage disease types I and III, and the malignant degeneration of adenomas in hepatocellular carcinoma has been reported in ten cases. The aim of this work was to study the characteristics of hepatic adenomas in a large series of 43 patients with glycogen storage disease types I and III and to determine the optimal means of follow‐up.Methods:The charts of 43 patients with glycogen storage disease type I and III were studied. In all these patients, abdominal ultrasonography and the determination of serum α‐fetoprotein had

APA, Harvard, Vancouver, ISO, and other styles

3

Shen, J., and Y. Chen. "Molecular Characterization of Glycogen Storage Disease Type III." Current Molecular Medicine 2, no. 2 (2002): 167–75. http://dx.doi.org/10.2174/1566524024605752.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Minen, Federico, Gabriele Cont, Angela De Cunto, et al. "Delayed Diagnosis of Glycogen Storage Disease Type III." Journal of Pediatric Gastroenterology and Nutrition 54, no. 1 (2012): 122–24. http://dx.doi.org/10.1097/mpg.0b013e318228d806.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Cleary, M. A., J. H. Walter, B. A. Kerr, and J. E. Wraith. "Facial appearance in glycogen storage disease type III." Clinical Dysmorphology 11, no. 2 (2002): 117–20. http://dx.doi.org/10.1097/00019605-200204000-00008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

MOSES, S. W., N. GADOTH, N. BASHAN, E. BEN-DAVID, A. SLONIM, and K. L. WANDERMAN. "Neuromuscular Involvement in Glycogen Storage Disease Type III." Acta Paediatrica 75, no. 2 (1986): 289–96. http://dx.doi.org/10.1111/j.1651-2227.1986.tb10201.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Korlimarla, Aditi, Stephanie Austin, Baodong Sun, and Priya Kishnani. "Hepatic Manifestations in Glycogen Storage Disease Type III." Current Pathobiology Reports 6, no. 4 (2018): 233–40. http://dx.doi.org/10.1007/s40139-018-0182-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Liu, Kai-Ming, Jer-Yuarn Wu, and Yuan-Tsong Chen. "Mouse model of glycogen storage disease type III." Molecular Genetics and Metabolism 111, no. 4 (2014): 467–76. http://dx.doi.org/10.1016/j.ymgme.2014.02.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Salemi, Vera Maria Cury, Léa Maria Macruz Ferreira Demarchi, Estêvan Vieira Cabeda, Jaqueline Wagenführ, and Ana Cristina Tanaka. "Type III glycogen storage disease mimicking hypertrophic cardiomyopathy." European Heart Journal - Cardiovascular Imaging 13, no. 2 (2011): 197. http://dx.doi.org/10.1093/ejechocard/jer231.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Zimakas, P. J. A. "Glycogen storage disease type III in Inuit children." Canadian Medical Association Journal 172, no. 3 (2005): 355–58. http://dx.doi.org/10.1503/cmaj.1031589.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Moses, S. W., K. L. Wanderman, A. Myroz, and M. Frydman. "Cardiac involvement in glycogen storage disease type III." European Journal of Pediatrics 148, no. 8 (1989): 764–66. http://dx.doi.org/10.1007/bf00443106.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Labrune, Ph, C. Benattar, N. Ammoury, J. Chalas, A. Lindenbaum та M. Odièvre. "Serum Concentrations of Albumin, C‐Reactive Protein, α₂‐Macroglobulin, Prealbumin, Fibronectin, Fibrinogen, Transferrin, and Retinol Binding Protein in 55 Patients with Hepatic Glycogen Storage Diseases". Journal of Pediatric Gastroenterology and Nutrition 18, № 1 (1994): 41–44. http://dx.doi.org/10.1002/j.1536-4801.1994.tb11120.x.

Full text

Abstract:

Summary:Hepatic glycogen storage diseases are hereditary metabolic disorders involving the metabolism of glycogen. This study was designed to investigate the serum protein status in such diseases. Fifty‐five patients with glycogen storage disease types I, III, VI, and IX, whose ages ranged from 1 month to 27 years, were included in this work. C‐reactive protein, fibrinogen, α2‐macroglobulin, albumin, transferrin, fibronectin, retinol binding protein, and prealbumin serum concentrations were measured in each patient. In patients affected with type I glycogen storage disease, serum concentration

APA, Harvard, Vancouver, ISO, and other styles

13

Gharpure, Varsha, Kalyani Raghavan, Meenakshi Mehta, and Alka Kalgutkar. "Glycogen storage disease type IIa." Indian Journal of Pediatrics 63, no. 2 (1996): 259–62. http://dx.doi.org/10.1007/bf02845254.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Fayssoil, Abdallah, Pascal Laforet, Vincent Gajdos, et al. "0224: Cardiac involvement in glycogen storage disease type III." Archives of Cardiovascular Diseases Supplements 8, no. 1 (2016): 35. http://dx.doi.org/10.1016/s1878-6480(16)30109-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Oki, Y., M. Okubo, S. Tanaka, K. Nakanishi, T. Kobayashi, and T. Murase. "Diabetes mellitus secondary to glycogen storage disease type III." Diabetic Medicine 17, no. 11 (2000): 810–12. http://dx.doi.org/10.1046/j.1464-5491.2000.00378.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Haller, R. G. "Glycogen storage disease type III: The phenotype branches out." Neurology 84, no. 17 (2015): 1726–27. http://dx.doi.org/10.1212/wnl.0000000000001532.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Galvin-Parton, P., and F. A. Hommes. "Abnormal oligosaccharide pattern in glycogen storage disease type III." Journal of Inherited Metabolic Disease 19, no. 3 (1996): 383–84. http://dx.doi.org/10.1007/bf01799279.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Tada, Hiroshi, Takashi Kurita, Tohru Ohe, et al. "Glycogen storage disease type III associated with ventricular tachycardia." American Heart Journal 130, no. 4 (1995): 911–12. http://dx.doi.org/10.1016/0002-8703(95)90097-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Hobson-Webb, Lisa D., Stephanie L. Austin, Deeksha S. Bali, and Priya S. Kishnani. "The electrodiagnostic characteristics of Glycogen Storage Disease Type III." Genetics in Medicine 12, no. 7 (2010): 440–45. http://dx.doi.org/10.1097/gim.0b013e3181cd735b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Kishnani, Priya S., Stephanie L. Austin, Pamela Arn, et al. "Glycogen Storage Disease Type III diagnosis and management guidelines." Genetics in Medicine 12, no. 7 (2010): 446–63. http://dx.doi.org/10.1097/gim.0b013e3181e655b6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Crushell, Ellen, Eileen P. Treacy, J. Dawe, M. Durkie, and Nicholas J. Beauchamp. "Glycogen storage disease type III in the Irish population." Journal of Inherited Metabolic Disease 33, S3 (2010): 215–18. http://dx.doi.org/10.1007/s10545-010-9096-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Spengos, Konstantinos, Helen Michelakakis, Adamantios Vontzalidis, Vasiliki Zouvelou, and Panagiota Manta. "Diabetes mellitus associated with glycogen storage disease type III." Muscle & Nerve 39, no. 6 (2009): 876–77. http://dx.doi.org/10.1002/mus.21201.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Burlina, A. B., S. Piovan, L. Grazian, and F. Zacchello. "MULTIPLE SCLEROSIS IN GLYCOGEN STORAGE DISEASE TYPE III (GSD-III). 842." Pediatric Research 39 (April 1996): 143. http://dx.doi.org/10.1203/00006450-199604001-00864.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Borowitz, Stephen M., and Harry L. Greene. "Cornstarch Therapy in a Patient with Type III Glycogen Storage Disease." Journal of Pediatric Gastroenterology and Nutrition 6, no. 4 (1987): 631–34. http://dx.doi.org/10.1002/j.1536-4801.1987.tb09364.x.

Full text

Abstract:

SummaryA child with type III glycogen storage disease is described. The patient presented with growth failure and hepatic dysfunction, and no clinical or biochemical evidence of myopathy. Institution of high protein nocturnal intragastric feedings was associated with improved growth and less hepatic dysfunction. Compliance with tube feedings was sporadic necessitating another approach to the patient's management. The use of oral cornstarch supplements enabled the child to maintain normoglycemia and was associated with clinical and biochemical improvement. Our experience with this child suggest

APA, Harvard, Vancouver, ISO, and other styles

25

Karwowski, Christine, Csaba Galambos, David Finegold, and Benjamin L. Shneider. "Markedly Elevated Serum Transaminases in Glycogen Storage Disease Type III." Journal of Pediatric Gastroenterology and Nutrition 52, no. 5 (2011): 621–23. http://dx.doi.org/10.1097/mpg.0b013e31820e6a55.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Gremse, D. A., J. C. Bucuvalas, and W. F. Balistreri. "Efficacy of cornstarch therapy in type III glycogen-storage disease." American Journal of Clinical Nutrition 52, no. 4 (1990): 671–74. http://dx.doi.org/10.1093/ajcn/52.4.671.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Maire, I., G. Mandon, and M. Mathieu. "First Trimester Prenatal Diagnosis of Glycogen Storage Disease Type III." Journal of Inherited Metabolic Disease 12, S2 (1989): 292–94. http://dx.doi.org/10.1007/bf03335402.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Shin, Y. S., M. Rieth, J. Tausenfreund, and W. Endres. "First Trimester Diagnosis of Glycogen Storage Disease Type II and Type III." Journal of Inherited Metabolic Disease 12, S2 (1989): 289–91. http://dx.doi.org/10.1007/bf03335401.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Seol, Jaehee, Seyong Jung, Hong Koh, Jowon Jung, and Yunkoo Kang. "Echocardiographic Assessment of Patients with Glycogen Storage Disease in a Single Center." International Journal of Environmental Research and Public Health 20, no. 3 (2023): 2191. http://dx.doi.org/10.3390/ijerph20032191.

Full text

Abstract:

Glycogen storage disease (GSD) is a hereditary metabolic disorder caused by enzyme deficiency resulting in glycogen accumulation in the liver, muscle, heart, or kidney. GSD types II, III, IV, and IX are associated with cardiac involvement. However, cardiac manifestation in other GSD types is unclear. This study aimed to describe whether energy deprivation and the toxic effects of accumulated glycogen affect the heart of patients with GSD. We evaluated the left ventricle (LV) wall mass, LV systolic and diastolic function and myocardial strain with conventional echocardiography and two-dimension

APA, Harvard, Vancouver, ISO, and other styles

30

Ondruskova, Nina, Tomas Honzik, Hana Kolarova, et al. "Aberrant apolipoprotein C-III glycosylation in glycogen storage disease type III and IX." Metabolism 82 (May 2018): 135–41. http://dx.doi.org/10.1016/j.metabol.2018.01.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Borowitz, Stephen M., and Harry L. Greene. "Cornstarch Therapy in a Patient with Type III Glycogen Storage Disease." Journal of Pediatric Gastroenterology and Nutrition 6, no. 4 (1987): 631–34. http://dx.doi.org/10.1097/00005176-198707000-00024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Kaji, M. "A case of Costello syndrome and glycogen storage disease type III." Journal of Medical Genetics 39, no. 2 (2002): 8e—8. http://dx.doi.org/10.1136/jmg.39.2.e8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Labrune, Philippe. "Absence of specific facial dysmorphy in glycogen storage disease type III." Clinical Dysmorphology 12, no. 3 (2003): 213. http://dx.doi.org/10.1097/00019605-200307000-00017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

BHATTI, Shazia, and Emma PARRY. "Successful pregnancy in a woman with glycogen storage disease type III." Australian and New Zealand Journal of Obstetrics and Gynaecology 46, no. 2 (2006): 168–69. http://dx.doi.org/10.1111/j.1479-828x.2006.00549.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Hershkovitz, E., A. Donald, M. Mullen, P. J. Lee, and J. V. Leonard. "Blood lipids and endothelial function in glycogen storage disease type III." Journal of Inherited Metabolic Disease 22, no. 8 (1999): 891–98. http://dx.doi.org/10.1023/a:1005687323096.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Lee, P., M. Burch, and J. V. Leonard. "Plasma creatine kinase and cardiomyopathy in glycogen storage disease type III." Journal of Inherited Metabolic Disease 18, no. 6 (1995): 751–52. http://dx.doi.org/10.1007/bf02436768.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Labrune, Philippe. "Absence of specific facial dysmorphy in glycogen storage disease type III." Clinical Dysmorphology 12, no. 3 (2003): 213. http://dx.doi.org/10.1097/01.mcd.0000052342.43310.35.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Pagliarani, Serena, Sabrina Lucchiari, Gianna Ulzi, et al. "Glycogen storage disease type III: A novel Agl knockout mouse model." Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1842, no. 11 (2014): 2318–28. http://dx.doi.org/10.1016/j.bbadis.2014.07.029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Demo, Erin, Donald Frush, Marcia Gottfried, et al. "Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?" Journal of Hepatology 46, no. 3 (2007): 492–98. http://dx.doi.org/10.1016/j.jhep.2006.09.022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Herlin, Bastien, Pascal Laforět, Philippe Labrune, Emmanuel Fournier, and Tanya Stojkovic. "Peripheral neuropathy in glycogen storage disease type III: Fact or myth?" Muscle & Nerve 53, no. 2 (2015): 310–12. http://dx.doi.org/10.1002/mus.24977.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Ding, Jia-Huan, T. de Barsy, Barbara I. Brown, Rosalind A. Coleman, and Yuan-Tsong Chen. "Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III." Journal of Pediatrics 116, no. 1 (1990): 95–100. http://dx.doi.org/10.1016/s0022-3476(05)81652-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Kishnani, Priya S., Baodong Sun, and Dwight D. Koeberl. "Gene therapy for glycogen storage diseases." Human Molecular Genetics 28, R1 (2019): R31—R41. http://dx.doi.org/10.1093/hmg/ddz133.

Full text

Abstract:

AbstractThe focus of this review is the development of gene therapy for glycogen storage diseases (GSDs). GSD results from the deficiency of specific enzymes involved in the storage and retrieval of glucose in the body. Broadly, GSDs can be divided into types that affect liver or muscle or both tissues. For example, glucose-6-phosphatase (G6Pase) deficiency in GSD type Ia (GSD Ia) affects primarily the liver and kidney, while acid α-glucosidase (GAA) deficiency in GSD II causes primarily muscle disease. The lack of specific therapy for the GSDs has driven efforts to develop new therapies for t

APA, Harvard, Vancouver, ISO, and other styles

43

Artan, R., O. P. van Diggelen, and J. G. M. Huijmans. "Glycogen storage disease type III with diagnosis complicated by gluten-sensitive enteropathy." Journal of Inherited Metabolic Disease 21, no. 4 (1998): 437–38. http://dx.doi.org/10.1023/a:1005331414257.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Preisler, Nicolai, Agnès Pradel, Edith Husu, et al. "Exercise intolerance in Glycogen Storage Disease Type III: Weakness or energy deficiency?" Molecular Genetics and Metabolism 109, no. 1 (2013): 14–20. http://dx.doi.org/10.1016/j.ymgme.2013.02.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Mishori-Dery, A., N. Bashan, S. Moses, et al. "RFLPs for linkage analysis in families with glycogen storage disease type III." Journal of Inherited Metabolic Disease 18, no. 2 (1995): 207–10. http://dx.doi.org/10.1007/bf00711768.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Larizza, D., G. Maggiore, D. Marzani, M. Maghnie, and R. Ciceri. "Difficult hGH treatment in a patient with type III glycogen storage disease." European Journal of Pediatrics 145, no. 1-2 (1986): 84–85. http://dx.doi.org/10.1007/bf00441862.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Derks, Terry G. J., and G. Peter A. Smit. "Dietary management in glycogen storage disease type III: what is the evidence?" Journal of Inherited Metabolic Disease 38, no. 3 (2014): 545–50. http://dx.doi.org/10.1007/s10545-014-9756-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Sentner, Christiaan P., Irene J. Hoogeveen, David A. Weinstein, et al. "Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome." Journal of Inherited Metabolic Disease 39, no. 5 (2016): 697–704. http://dx.doi.org/10.1007/s10545-016-9932-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Anwar, Sayeeda, AKM Matiur Rahaman, Abdul Matin, Dipa Saha, and Maliha Rashid. "Glycogen Storage Disease Type III-Coris Disease: A Case Report and Review Literature." Bangladesh Journal of Child Health 39, no. 3 (2017): 161–63. http://dx.doi.org/10.3329/bjch.v39i3.31584.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Jahun, Mahmud Gambo, and Umar Isa Umar. "Glycogen Storage Disease Type III Presenting as Recurrent Seizure Disorder in a Second Twin: A Case Report." Bayero Journal of Nursing and Health Care 5, no. 1 (2023): 1185–90. http://dx.doi.org/10.4314/bjnhc.v5i1.8.

Full text

Abstract:

Glycogen storage diseases (GSDs) are a group of genetic autosomal recessive metabolic disorders resulting from deficiencies of enzymes of glycogen metabolism occurring in the liver, muscles or kidneys. Various types and sub-types exist based on genetic classification presenting with symptoms and signs of hypoglycaemia, hepatomegaly and myopathy depending on severity, and age of onset. A high index of suspicion is required for the diagnosis of GSDs. An eighteen-month-old girl who was apparently healthy with normal development was without any abnormality until about 12 months of age when she had

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!